Key result
Middle-aged women with essential hypertension carrying the CYP11B2 C allele had significantly lower nocturnal blood pressure reduction (7.4 vs 11.71 mmHg) and higher prevalence of non-dipping hypertension.
Why the study?
Does the -344T>C polymorphism of the CYP11B2 gene affect 24-hour blood pressure profiles in middle-aged women with essential hypertension?
Cross-Sectional (n=137)
No
Does the -344T>C polymorphism of the CYP11B2 gene affect 24-hour blood pressure profiles in middle-aged women with essential hypertension?
Absolute Event Rate: 7.4% vs 11.71%
p-value: p=0.004
The C allele of the CYP11B2 gene is associated with impaired nocturnal blood pressure dipping and higher nocturnal blood pressure in middle-aged women with essential hypertension.
May link CYP11B2 variant to BP patterns in hypertensive women; leaves open causal role and clinical utility.
Background In this cross-sectional study, we assessed the impact of –344T>C polymorphism of the CYP11B2 gene which encodes aldosterone synthase on 24-hour blood pressure patterns. Material and methods The study was performed in 137 females with essential hypertension aged 42−60 years. We measured plasma aldosterone level and renin activity (PRA), fasting glucose, lipid profiles and 24-hour urinary sodium and potassium excretion. Based on 24-hour blood pressure monitoring we identified cases with dipping and non-dipping patterns of blood pressure. Results Mean PRA and aldosterone levels and aldosterone-to-renin ratio (ARR) were within normal range. Non-dipping hypertension was found in 54.3% of patients. Genotype frequencies of TT, CC and CT were 27%, 27% and 46%, respectively. Carriers of the C allele had significantly lower nocturnal blood pressure reduction (P = 0.004) and higher nocturnal systolic (P = 0.02) and diastolic blood pressure (P = 0.044), frequency of non-dipping profile (P = 0.001), and 24-hour urinary potassium excretion (P = 0.047). Urinary sodium excretion was positively correlated with a decrease in nocturnal blood pressure (R = 0.202; P = 0.037). In a multiple regression analysis, ARR and presence of the C allele adjusted for confounding variables were inversely associated with the nocturnal blood pressure decline (b = −0.348; P = 0.022 and b = −0.222; P = 0.018, respectively). Conclusions In conclusion, in middle-aged females with essential hypertension carrying the C allele we found higher nocturnal blood pressure, lower nocturnal blood pressure reduction, and higher prevalence of non-dipping hypertension than in TT carriers.
No takes yet. Share an insight, caveat, or question.
Sołtysiak et al. (2015) conducted a cross-sectional in Essential hypertension (n=137). CYP11B2 -344T>C polymorphism C allele (TC/CC genotypes) vs. TT genotype was evaluated on Nocturnal blood pressure decline (mmHg) (p=0.004). Middle-aged women with essential hypertension carrying the CYP11B2 C allele had significantly lower nocturnal blood pressure reduction (7.4 vs 11.71 mmHg) and higher prevalence of non-dipping hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: